Q&A with Schenk AccuRate's Chad Lorensen

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-05-02-2010, Volume 34, Issue 5

Lorensen discusses client demands and industry trends.

Q & A with

Chad Lorensen, pharmaceutical industry business-development manager of Schenck AccuRate

PharmTech:

What is the biggest industry challenge you're now facing?

Lorensen

Advertisement

The development of continuous manufacturing processes. We are monitoring, helping where we can, and working with companies in the pharmaceutical industry who are studying continuous manufacturing processes for solid dosage products. Our core products have the strengths that provide value for this type of manufacturing process.

PharmTech:

How do you stay abreast of new developments in the industry?

Lorensen

Schenck stays abreast of the latest industry developments through regular communication with our customers, developing strong working relationships with other pharmaceutical-industry equipment manufacturers, and by participating in research consortiums at various universities. Further information is gathered by reviewing various pharmaceutical periodicals and attending trade show exhibitions. In addition, Schenck is a global company, and each of its offices can share ideas with other Schenck locations throughout the world.

PharmTech:

Do you see a new industry trend emerging?

Lorensen

We are looking forward to the pharmaceutical industry's acceptance of continuous mixing, granulation, and hot-melt extrusion.

PharmTech:

What is the most common demand your clients are currently making of you?

Lorensen

The most common request is to provide equipment to customers' sites for trials and experiments made in conjunction with other types of continuous processing equipment.